Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research
ID: 359945Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359945
Timeline
    Description

    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research." This initiative aims to support the secondary use of archived data and biospecimen collections to enhance research in maternal, pediatric, and adolescent HIV, encouraging the integration of innovative data science methods and interdisciplinary approaches. With an estimated total program funding of $1,000,000 and the expectation of awarding two grants, interested small businesses can reach out to Samantha Calabrese at samantha.calabrese@nih.gov or call 301-827-7568 for more information. Key deadlines include an estimated synopsis post date of October 1, 2025, and a closing date of January 2, 2026, with project start and award dates anticipated for July 1, 2026.

    Point(s) of Contact
    Samantha Calabrese, M.P.H. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    (301) 827-7568
    samantha.calabrese@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for HIV Pediatric, Adolescent and Maternal Clinical Trials
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for research focused on high-priority HIV studies targeting infants, children, adolescents, young adults, and maternal populations. This initiative aims to establish an HIV clinical trials network dedicated to these demographics, fostering innovative and collaborative clinical trials to address significant research areas in HIV and related health issues. The estimated total program funding is $30 million, with two awards anticipated, and potential applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on November 21, 2025. For further inquiries, interested parties may contact Dr. Sonia Lee at Sonia.lee@nih.gov or by phone at 301-594-4783.
    Martin Delaney Collaboratories for HIV Cure Research
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Martin Delaney Collaboratories for HIV Cure Research," aimed at advancing research strategies to control HIV replication and ultimately eradicate HIV reservoirs. This initiative seeks to foster collaborations among academic institutions, government scientists, the private sector, and community stakeholders to accelerate HIV cure research, particularly addressing the needs of children living with HIV. The estimated total program funding is $20 million, with six awards expected to be granted, and interested small businesses can reach out to Diane Lawrence, Ph.D., at diane.lawrence2@nih.gov or call 240-627-3202 for more information. Key deadlines include an estimated synopsis post date of April 21, 2026, and a close date of August 19, 2026, with awards anticipated by March 1, 2027.
    Advancing Prevention and Treatment of Bacterial STIs in HIV-affected Adolescent and Maternal Populations
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Advancing Prevention and Treatment of Bacterial STIs in HIV-affected Adolescent and Maternal Populations." This initiative aims to support research, including clinical trials, focused on bacterial sexually transmitted infections (STIs) in adolescent and maternal populations impacted by HIV, with an emphasis on diagnostic advancements, microbicidal agents, and evidence-based prevention and treatment strategies. The total estimated funding for this program is $2,000,000, with three awards expected to be granted. Interested applicants, particularly small businesses, should note that the application deadline is January 7, 2026, and they can reach out to Franklin W. Yates, MD, at franklin.yates@nih.gov or by phone at 301-827-5536 for further inquiries.
    Implementation Science to End the HIV Epidemic
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Implementation Science to End the HIV Epidemic," aimed at advancing efforts to combat HIV through innovative research-community collaborations. The initiative seeks projects that will develop and evaluate strategies for HIV prevention, diagnosis, treatment, and outbreak response, particularly in communities disproportionately affected by the epidemic. This funding, totaling an estimated $7 million, will support approximately 10 awards, with applications open to a diverse range of eligible entities, including tribal governments, federal agencies, and community-based organizations. Interested applicants should note that the estimated synopsis close date is April 17, 2026, and the anticipated award date is December 1, 2026; for further inquiries, contact Rebecca Mandt, Ph.D., at rebecca.mandt@nih.gov or call 301-435-7695.
    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "Priority HIV/AIDS Research" under the R01 grant mechanism. This initiative aims to stimulate research that aligns with NIH’s priorities regarding HIV/AIDS, particularly focusing on systemic complications such as metabolic, gastrointestinal, and kidney issues arising from HIV, while encouraging the incorporation of health-impeding social determinants of health into research proposals. The anticipated funding amount is $2 million, with plans to support 3 to 5 awards over five years, and applications are due starting May 7, 2025. Interested applicants can find more information and application guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIAID Resource-Related Research Projects
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIAID Resource-Related Research Projects," aimed at supporting investigator-initiated research that develops essential resources for biomedical research. This program encourages small businesses to propose non-hypothesis-driven activities that provide high-quality data, materials, tools, or services relevant to the NIAID mission, which includes areas such as infectious diseases, immune function, and translational research for vaccines and therapeutics. Interested applicants should note that there is no cost-sharing requirement, and the estimated synopsis close date is January 26, 2026, with awards expected to be made by December 1, 2026. For further inquiries, applicants can contact Dr. Chelsea Boyd at chelsea.boyd@nih.gov or by phone at 301-761-6664.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to HIV/AIDS within the National Institute on Deafness and Other Communication Disorders (NIDCD). This initiative encourages applications that address high-priority research areas identified by the NIH Office of AIDS Research, particularly focusing on the intersections of HIV/AIDS with hearing, communication, and associated disorders. Grants of up to $499,999 in direct costs are available for projects lasting up to five years, with no cost-sharing or matching requirements. Interested applicants, including educational institutions and community organizations, must adhere to NIH guidelines and submit their proposals through Grants.gov by the closing date of January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV) program, aimed at advancing research in the field of infectious diseases. This initiative seeks to support innovative research that elucidates mechanisms of persistence and pathogenesis of Hepatitis B, develops clinically relevant biomarkers, identifies new drug targets, and creates non-invasive diagnostics, leveraging existing clinical data and sample repositories. With an estimated total program funding of $8 million and the expectation of awarding two grants, interested small businesses should note that the application process is open, with key deadlines including an estimated synopsis close date of August 19, 2026, and an anticipated award date of March 1, 2027. For further inquiries, applicants can contact Josh Radke, Ph.D., at josh.radke@nih.gov or by phone at 301-761-6525.